Why Your Liver Cancer Screening Probably Isn’t Enough
If you have hepatitis, cirrhosis, or NAFLD, your doctor may be relying on ultrasound and AFP — tools that miss over 40% of early-stage HCC. Here’s what the evidence shows.
Category: Patient Education